Brain Glioblastoma
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma (NCT04388475) | Oblato, Inc. | 2020-06-12 |
| Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer (NCT03154190) | Stanford University | 2017-08-08 |
Track Brain Glioblastoma automatically
Every clearance here is in the API, with alerts when new ones post.